Clinical Profiles, Demographic Features, and Maternal Outcomes among Coronavirus Disease Positive Pregnant Women: A Cross-sectional Study
DOI:
https://doi.org/10.3889/oamjms.2021.6183Keywords:
Pregnant women, Coronavirus disease 2019, NeonatesAbstract
BACKGROUND: Pregnant women are susceptible to coronavirus infection due to physiological changes in the circulatory and immunological parameters.
AIM: The current study aimed to determine the demographic factors, clinical symptoms, and fetal-maternal outcomes and also compare the blood parameters and chest X-ray results among coronavirus disease 2019 (COVID-19) positive and negative pregnant women.
MATERIALS AND METHODS: Complete blood count and Chest X-rays were performed as a routine in all pregnant women. Polymerase chain reaction for COVID-19 was performed for all women and the newborn.
RESULTS: The blood parameters revealed that a significantly greater proportion of COVID-19 positive pregnant women had abnormal hemoglobin, total leukocyte count, neutrophil count, lymphocyte count, monocyte count, bilirubin, aspartate aminotransferase, alanine aminotransferase, and urea.
CONCLUSIONS: The present study provided crucial insights into epidemiological and clinical features during the perinatal period. Chest X-rays and blood routine examination are reliable findings to prevent COVID-19 complications among pregnant women.Downloads
Metrics
Plum Analytics Artifact Widget Block
References
World Health Organization. Coronavirus Disease 2019 (COVID-19): Situation Report. Geneva: World Health Organization; 2020. p. 60.
Schwartz DA. An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: Maternal coronavirus infections and pregnancy outcomes. Arch Pathol Lab Med. 2020;144(7):799-805. https://doi.org/10.5858/arpa.2020-0901-sa PMid:32180426 DOI: https://doi.org/10.5858/arpa.2020-0901-SA
Arbabzadeh T, Noori N, Najafian A, Ghasemi M. Assessment of corona in pregnant women: Epidemiology, clinical signs, prevention and treatment. J Complement Med Res. 2020;11(3):118-30. https://doi.org/10.5455/jcmr.2020.11.03.15 DOI: https://doi.org/10.5455/jcmr.2020.11.03.15
Ellington S, Strid P, Tong VT, Woodworth K, Galang RR, Zambrano LD, et al. Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status-United States, January 22-June 7, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(25):769. https://doi.org/10.15585/mmwr.mm6925a1 PMid:32584795 DOI: https://doi.org/10.15585/mmwr.mm6925a1
Badr DA, Mattern J, Carlin A, Cordier AG, Maillart E, El Hachem L, et al. Are clinical outcomes worse for pregnant women at≥ 20 weeks’ gestation infected with coronavirus disease 2019? A multicenter case-control study with propensity score matching. Am J Obstet Gynecol. 2020;223(5):764-8. https://doi.org/10.1016/j.ajog.2020.07.045 PMid:32730899 DOI: https://doi.org/10.1016/j.ajog.2020.07.045
Yu N, Li W, Kang Q, Xiong Z, Wang S, Lin X, et al. Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: A retrospective, single-centre, descriptive study. Lancet Infect Dis. 2020;20(5):559-64. https://doi.org/10.1016/s1473-3099(20)30176-6 DOI: https://doi.org/10.1016/S1473-3099(20)30176-6
Anand P, Yadav A, Debata P, Bachani S, Gupta N, Gera R. Clinical profile, viral load, management and outcome of neonates born to COVID 19 positive mothers: A tertiary care centre experience from India. Eur J Pediatr. 2020;180(2):547-59. https://doi.org/10.1007/s00431-020-03800-7 PMid:32910210 DOI: https://doi.org/10.1007/s00431-020-03800-7
Centers for Disease Control and Prevention. Centers for Disease Control and Prevention Coronavirus Disease 2019 (COVID-19) 2020. United States: Centers for Disease Control and Prevention; 2020.
Government of Pakistan. Sexual Reproductive and Maternal Health Services during COVID-19. 2020. Available from: https://www.covid.gov.pk/guideline.
Panahi L, Amiri M, Pouy S. Risks of novel coronavirus disease (COVID-19) in pregnancy; a narrative review. Arch Acad Emerg Med. 2020;8(1):e34. PMid:32232217
Perrone S, Deolmi M, Giordano M, D’Alvano T, Gambini L, Corradi M, et al. Report of a series of healthy term newborns from convalescent mothers with COVID-19. Acta Biomed. 2020;91(2):251. PMid:32420961
Sahin D, Tanacan A, Erol SA, Anuk AT, Yetiskin FD, Keskin HL, et al. Updated experience of a tertiary pandemic center on 533 pregnant women with COVID-19 infection: A prospective cohort study from Turkey. Int J Gynaecol Obstet. 2021;152(3):328-34. https://doi.org/10.1002/ijgo.13460 DOI: https://doi.org/10.1002/ijgo.13460
Yang H, Sun G, Tang F, Peng M, Gao Y, Peng J, et al. Clinical features and outcomes of pregnant women suspected of coronavirus disease 2019. J Infect. 2020;81(1):e40-4. https://doi.org/10.1016/j.jinf.2020.04.003 DOI: https://doi.org/10.1016/j.jinf.2020.04.003
Ashraf MA, Keshavarz P, Hosseinpour P, Erfani A, Roshanshad A, Pourdast A, et al. Coronavirus disease 2019 (COVID-19): A systematic review of pregnancy and the possibility of vertical transmission. J Reprod Infertil. 2020;21(3):157-68. PMid:32685412
Zaigham M, Andersson O. Maternal and perinatal outcomes with COVID-19: A systematic review of 108 pregnancies. Acta Obstet Gynecol Scand. 2020;99(7):823-9. https://doi.org/10.1111/aogs.13867 PMid:32259279 DOI: https://doi.org/10.1111/aogs.13867
Tanacan A, Erol SA, Turgay B, Anuk AT, Secen EI, Yegin GF, et al. The rate of SARS-CoV-2 positivity in asymptomatic pregnant women admitted to hospital for delivery: Experience of a pandemic center in Turkey. Eur J Obstet Gynecol Reprod Biol. 2020;253:31-4. https://doi.org/10.1016/j.ejogrb.2020.07.051 PMid:32763728 DOI: https://doi.org/10.1016/j.ejogrb.2020.07.051
Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. Clinical and immunologic features in severe and moderate forms of coronavirus disease. J Clin Invest. 2019;130(5):2620-9. PMid:32217835
Wang C, Deng R, Gou L, Fu Z, Zhang X, Shao F, et al. Preliminary study to identify severe from moderate cases of COVID-19 using combined hematology parameters. Ann Transl Med. 2020;8(9):593. https://doi.org/10.21037/atm-20-3391 PMid:32566620 DOI: https://doi.org/10.21037/atm-20-3391
Turan O, Hakim A, Dashraath P, Jeslyn WJ, Wright A, Abdul-Kadir R. Clinical characteristics, prognostic factors, and maternal and neonatal outcomes of SARS-CoV-2 infection among hospitalized pregnant women: A systematic review. Int J Gynecol Obstet. 2020;151(1):7-16. https://doi.org/10.1002/ijgo.13329 PMid:32816307 DOI: https://doi.org/10.1002/ijgo.13329
Zeng L, Xia S, Yuan W, Yan K, Xiao F, Shao J. Neonatal early-onset infection with SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan, China. JAMA Ped. 2020;174(7):722-5. https://doi.org/10.1001/jamapediatrics.2020.0878 PMid:32215598 DOI: https://doi.org/10.1001/jamapediatrics.2020.0878
Rasmussen SA, Smulian JC, Lednicky JA, Wen TS, Jamieson DJ. Coronavirus disease 2019 (COVID-19) and pregnancy: What obstetricians need to know. Am J Obstetr Gynecol. 2020;222(5):415-26. https://doi.org/10.1016/j.ajog.2020.02.017 PMid:32105680 DOI: https://doi.org/10.1097/01.aoa.0000719440.84472.52
Rasmussen SA, Kissin DM, Yeung LF, MacFarlane K, Chu SY, Turcios-Ruiz RM, et al. Preparing for influenza after 2009 H1N1: Special considerations for pregnant women and newborns. Am J Obstet Gynecol. 2011;204(6):S13-20. https://doi.org/10.1016/j.ajog.2011.01.048 PMid:21333967 DOI: https://doi.org/10.1016/j.ajog.2011.01.048
Mirzadeh M, Khedmat L. Pregnant women in the exposure to COVID-19 infection outbreak: The unseen risk factors and preventive healthcare patterns. J Matern Fetal Neonatal Med. 2009:1-2. https://doi.org/10.1080/14767058.2020.1749257 PMid:32223477 DOI: https://doi.org/10.1080/14767058.2020.1749257
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2020 Zaheera Saadia, Robina Farrukh, Sumaira Kanwal, Quratulain Shahzad (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0
